The upper and lower airway responses to nasal challenge with house-dust mite Blomia tropicalis

D Y Wang1, D Y T Goh, A K L Ho

  • 1Department of Otolaryngology, The National University of Singapore, Singapore.

Allergy
|February 13, 2003
PubMed
Abstract

Insights

This study shows that the house dust mite Blomia tropicalis triggers allergic nasal responses in sensitized adults. Nasal challenges with this mite can also lead to asthma symptoms, particularly in those with a history of asthma.

Area of Science:

  • Allergy and Immunology
  • Respiratory Medicine
  • Environmental Health

Background:

  • Blomia tropicalis is the most common domestic mite in Singapore.
  • Its role in allergic airway diseases requires investigation.

Purpose of the Study:

  • To investigate the pathogenicity of Blomia tropicalis in adults with persistent allergic rhinitis.
  • To assess the direct allergic nasal response to B. tropicalis.

Main Methods:

  • Nasal challenge tests were performed on 20 adults with persistent allergic rhinitis using B. tropicalis extracts.
  • Subjective and objective nasal symptoms, spirometry (FEV1), and nasal mediator concentrations (tryptase, LTC4, ECP) were measured.
  • Control challenges with phosphate-buffered saline (PBS) were conducted.

Main Results:

  • B. tropicalis challenge caused significant increases in nasal symptoms and mediator concentrations.
  • No consistent late-phase nasal response was observed.
  • Three out of five patients with asthma history experienced decreased FEV1 and mild wheezing post-challenge.

Conclusions:

  • Direct evidence of allergic nasal response to B. tropicalis in sensitized adults was demonstrated.
  • Nasal provocation with B. tropicalis may trigger asthma symptoms, especially in individuals with pre-existing asthma.

Related Concept Videos

Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...